Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
People channel feed
Shattuck Labs cuts CD47 program and 40% of workforce as it focuses on IBD drug
7 months ago
R&D
IGM scraps oncology work to focus on autoimmune, loses three executives
7 months ago
R&D
Ensoma shutters Copenhagen site from its Twelve Bio acquisition
7 months ago
Startups
SIGA is 'deeply angered' by former exec's 'inaccurate' comments about mpox antiviral
7 months ago
SIGA fires former NYC Covid advisor after secret recordings detail pandemic-era parties
7 months ago
Pharma
Samsara adds three venture partners to help steer and advise portfolio companies
7 months ago
Sanofi hires Mike Quigley as next chief scientist, internal memo says
7 months ago
Pharma
Updated: Gene therapy maker bluebird bio cuts costs again, lays off staff
7 months ago
Cell/Gene Tx
Q&A: Bristol Myers’ tech chief on the promises and perils of AI bio
7 months ago
R&D
AI
Lasker Award goes to three scientists who pioneered research behind GLP-1 drugs
7 months ago
Discovery
Exclusive: Flagship-backed Valo Health loses interim CEO ahead of key Phase 2 readout
7 months ago
Startups
AI
All of 23andMe's independent board members resign over disagreements with CEO
7 months ago
Health Tech
Bad trip: How culture conflict and a need for cash nearly broke Lykos
7 months ago
In Focus
Ochre Bio CEO Jack O’Meara steps down, outlines plans for next startup
7 months ago
Startups
Ex-Kite leaders step in at Kyverna as CEO exits after landing year's second-biggest IPO
7 months ago
Cell/Gene Tx
Merck's Eliav Barr on subcutaneous Keytruda, Summit and deal shopping
7 months ago
R&D
Arbor Biotechnologies cuts early-stage discovery work, lays off staff
7 months ago
R&D
Aurinia restructures board, bringing in Kevin Tang and keeping CEO
7 months ago
Charles River to lay off 3% of staffers as it streamlines spending
8 months ago
Manufacturing
Former Verily execs launch effort to transform clinical trials
8 months ago
Financing
Health Tech
Lilly again hires from within for CFO post, elevating 23-year company veteran
8 months ago
Pharma
Non-viral delivery startup Vesigen Therapeutics trims staff as it evaluates 'strategic options'
8 months ago
Startups
Pharma
Updated: Lykos CEO Amy Emerson resigns
8 months ago
IN8bio pauses glioblastoma program, halves workforce as it prioritizes leukemia asset
8 months ago
R&D
First page
Previous page
5
6
7
8
9
10
11
Next page
Last page